Survival comparing outcomes between patients with any occult leukemia detectable by flow cytometry at the end of consolidation therapy censoring for allogeneic transplant.

Overall survival 3 years after the end of consolidation was 41% ± 26% versus 69% ± 10% for patients with and without occult leukemia, respectively (P = .0058). n = 128 patients.